VistaGen's Long-Term Relationship With Global Contract Research and Development Organization Expands to Include Right-of-First-Offer for Potential Drug Rescue Candidates SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 02/08/12 -- VistaGen Therapeutics, Inc.

Collaboration to Focus on Leveraging VistaGen's Stem Cell-Based Technology to Develop Safer, Drug Rescue Variants of Once-Promising Drug Candidates SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 12/07/11 -- VistaGen Therapeutics, Inc. (OTCBB: VSTA), a biotechnology company applying stem cell

Company Holds Exclusive Worldwide Rights to Intellectual Property Arising From These Discoveries SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 10/25/11 -- VistaGen Therapeutics, Inc. (OTCBB: VSTA), a biotechnology company applying stem cell technology for drug rescue and cell therapy, announces the

SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 10/05/11 -- VistaGen Therapeutics, Inc. (OTCBB: VSTA), a biotechnology company applying stem cell technology for drug rescue and cell therapy, announces a poster presentation of its research and development activities leading to validation of its human

SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 09/28/11 -- VistaGen Therapeutics, Inc. (OTCBB: VSTA), a biotechnology company applying stem cell technology for drug rescue and cell therapy, announces the issuance of two additional United States patents supporting its therapeutic and drug discovery

SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 09/26/11 -- VistaGen Therapeutics, Inc. (OTCBB: VSTA), a biotechnology company applying stem cell technology for drug rescue and cell therapy, announces the publication of its original research demonstrating the use of pluripotent stem cells to generate

SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- 09/14/11 -- VistaGen Therapeutics, Inc. (OTCBB: VSTA), a biotechnology company primarily focused on applying stem cell technology for drug rescue and cell therapy, today provides a comprehensive update on the Company's strategic plan to develop and